Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
is an orally bioavailable small-molecule SMO (Smoothened) inhibitor with potential antineoplastic activity
Receptor assays showed that trospium chloride has negligible affinity for nicotinic receptors as compared to muscarinic receptors at concentrations obtained from therapeutic doses
In the complete Freund's adjuvant model of inflammatory pain
T16AinhA01
ARRY-380 Size:Solid 2 mg is an orally bioavailable small-moleculeARRY 380 analog is an analog of ARRY 380. ARRY 380 is also know as Tucatinib, also known as Irbinitinib, and ONT 380, is a n orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB 2 (also called HER2) with potential antineoplastic activity. ErbB 2 inhibitor ARRY 380 selectively binds to and inhibits the phosphorylation of ErbB 2, which may prevent the activation of ErbB 2 signal transduction pathways,
US$ 1166.00
US$ 1371.50
US$ 38.00
US$ 69.00
US$ 1099.50
US$ 44.00
US$ 12004.50
US$ 28.00
US$ 44.10
US$ 34.00
US$ 44.00